Cargando…
NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes
Epigenetics alternation of non-genetic variation and genome-wide association study proven allelic variants may associate with insulin secretion in type 2 diabetes (T2D) development. We analyzed promoter DNA methylation array to evaluate the associated with increased susceptibility to T2D (30 cases,...
Autores principales: | Chen, Yng-Tay, Lin, Wei-De, Liao, Wen-Ling, Tsai, Ya-Ching, Liao, Jiunn-Wang, Tsai, Fuu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527562/ https://www.ncbi.nlm.nih.gov/pubmed/32999320 http://dx.doi.org/10.1038/s41598-020-71336-9 |
Ejemplares similares
-
Author Correction: NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes
por: Chen, Yng‑Tay, et al.
Publicado: (2021) -
Inhibition of DNA methyltransferase 1 increases nuclear receptor subfamily 4 group A member 1 expression and decreases blood glucose in type 2 diabetes
por: Chen, Yng-Tay, et al.
Publicado: (2016) -
PTPRD silencing by DNA hypermethylation decreases insulin receptor signaling and leads to type 2 diabetes
por: Chen, Yng-Tay, et al.
Publicado: (2015) -
Effects of Acrylamide-Induced Vasorelaxation and Neuromuscular Blockage: A Rodent Study
por: Lin, Wei-De, et al.
Publicado: (2021) -
Personalized medicine in Type 2 Diabetes
por: Liao, Wen-Ling, et al.
Publicado: (2014)